A REVIEW ON IN SILICO APPROACH IN PHARMACOLOGY *

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• PHARMACOPHORE PERCEPTION , DEVELOPMENT , AND USE IN DRUG DESIGN

  2011cited by this paper
• In silico pharmacology for drug discovery: applications to targets and beyond

  2007cited by this paper
• In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling

  2007cited by this paper
• The Biochemistry of Drug Metabolism – An Introduction

  2007cited by this paper
• Γ and B

  2004cited by this paper
• ADMET in silico modelling: towards prediction paradise?

  2003cited by this paper
• AI and SAR approaches for predicting chemical carcinogenicity: Survey and status report

  2002cited by this paper
• Computer systems for the prediction of toxicity: an update.

  2002cited by this paper
• Handbook of Molecular Descriptors

  2002cited by this paper
• High-throughput and in silico techniques in drug metabolism and pharmacokinetics.

  2002cited by this paper
• Computational methods to predict drug safety liabilities.

  2001cited by this paper
• Pharmacophore and three-dimensional quantitative structure activity relationship methods for modeling cytochrome p450 active sites.

  2001cited by this paper
• Molecular fields in quantitative structure–permeation relationships: the VolSurf approach

  2000cited by this paper
• Three- and four-dimensional-quantitative structure activity relationship (3D/4D-QSAR) analyses of CYP2C9 inhibitors.

  2000cited by this paper
• High-throughput and ultra-high-throughput screening: solution- and cell-based approaches.

  2000cited by this paper
• A novel approach to predicting P450 mediated drug metabolism. CYP2D6 catalyzed N-dealkylation reactions and qualitative metabolite predictions using a combined protein and pharmacophore model for CYP2D6.

  1999cited by this paper
• Managing the drug discovery/development interface

  1997cited by this paper
• From data banks to data bases.

  1991cited by this paper

• Assessment of the potential toxic of naringenin nanoparticles using ex vivo and in silico models.

  2025cites this paper
• Computational study of molecular electrostatic potential, docking and dynamics simulations of gallic acid derivatives as ABL inhibitors

  2018cites this paper
• Eksistensi jamu sebagai minuman tradisional di dunia penelitian modern dan potensinya dalam kajian in silico

  2018cites this paper
• Reduction, replacement and ethics of animal use in bio-science research and education

  2017cites this paper
• Selecting oral bioavailability enhancing formulations during drug discovery and development

  2014cites this paper